BK vs STRO
The Bank of New York Mellon Corporation (BK) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BK and STRO stock pages for the full models.
Not investment advice.